Does prior antithrombotic therapy influence recurrence and bleeding risk in stroke patients with atrial fibrillation or atrial flutter?
Citation
Gamble , D T , Buono , R , Mamas , M A , Leslie , S , Bettencourt-Silva , J H , Clark , A B , Bowles , K M , Metcalf , A K , Potter , J F & Myint , P K 2020 , ' Does prior antithrombotic therapy influence recurrence and bleeding risk in stroke patients with atrial fibrillation or atrial flutter? ' , European Journal of Preventive Cardiology , vol. 27 , no. 7 , pp. 729-737 . https://doi.org/10.1177/2047487319871709
URI
http://hdl.handle.net/2164/12684http://www.mendeley.com/research/prior-antithrombotic-therapy-influence-recurrence-bleeding-risk-stroke-patients-atrial-fibrillation
Rights
This is the author's version of an article accepted for publication in Gamble et al, Does prior antithrombotic therapy influence recurrence and bleeding risk in stroke patients with atrial fibrillation or atrial flutter?, European Journal of Preventive Cardiology 27(7) pp. 729-737. Copyright: The European Society of Cardiology 2019. https://doi.org/10.1177/2047487319871709